Literature DB >> 24856084

The effect of pre-donation hypotension on whole blood donor adverse reactions: a systematic review.

Nele S Pauwels1, Leila Cusack2, Emmy De Buck2, Veerle Compernolle3, Philippe Vandekerckhove4.   

Abstract

Blood services are reliant upon healthy blood donors to provide a safe and adequate supply of blood products. Inappropriate variables contained within blood donor exclusion criteria can defer potentially appropriate donors. The aim of this systematic review was to examine the effect of low pre-donation blood pressure, as compared with normal blood pressure, on adverse events in allogeneic whole blood donors. A systematic review was performed using highly sensitive search strategies within five databases (Cochrane Central Register of Controlled Trials, CINAHL, Embase, MEDLINE, and Web of Science) from inception date until April 12, 2013. Out of 8305 records, 10 observational studies were identified that addressed the question. Five of these studies (with a combined total of 1,482,020 donations and 2903 donors) included either a statistical analysis or an appropriate study design that controlled for possible confounding factors. Based on the currently available evidence, hypotension has not been shown to be an independent predictive factor for donor complications. However, the overall quality of evidence was rather limited and rated 'low,' using the GRADE approach. In conclusion there is currently no evidence that hypotensive blood donors have a greater risk for donor adverse events compared with their normotensive counterparts.
Copyright © 2014 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse reaction; blood pressure; donor safety; whole blood donation

Mesh:

Year:  2014        PMID: 24856084     DOI: 10.1016/j.jash.2014.03.332

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  1 in total

1.  A Cross-Sectional Study of Blood Donors' Psychological Characteristics over 8 Weeks.

Authors:  Max Esefeld; Ariane Sümnig; Ulf Alpen; Hans Jörgen Grabe; Andreas Greinacher
Journal:  Transfus Med Hemother       Date:  2021-08-23       Impact factor: 4.040

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.